Huafeng Wei Department of Anesthesiology and Critical Care, Perelman School of Medicine University of Pennsylvania Philadelphia, PA (United States)
Dr. Huafeng Wei is an Associate Professor with Tenure
at the Department of Anesthesiology at the University of
Pennsylvania in the U.S.A. Dr. Wei completed his
medical graduate student education and training in
Anesthesiology at Tongji Medical University in 1988. He
obtained his Ph.D. in pharmacology and toxicology from
the George Washington University in 1996 and
completed his postdoctoral training at Georgetown
University and National Institute of Health (NIH) in 1999.
He completed his second resident training in
Anesthesiology and Critical Care at the University of Pennsylvania in 2003 and become
a standing faculty member thereafter at UPENN. His lab has focused on studying the
role of calcium dysregulation in neurodegeneration in various neurodegenerative
diseases, especially in Alzheimer’s disease and after various general anesthetics
treatments. His lab is the first to demonstrate that dantrolene, a drug for treatment of
malignant hyperthermia, can abolish the memory and learning impairment in various
animal models of Alzheimer’s disease. Dr. Wei has been an invited speaker for Harvard,
Johns Hopkins, UCSF, Duke, UVA, Imperial College of England, University of
Heidelberg in Germany, University of Padova in Italy, as well as speakers for
international conferences in more than 10 countries and regions.
Shengzhou Wu School of Optometry and Ophthalmology and Eye Hospital Wenzhou Medical University Wenzhou (China)
Prof. Shengzhou Wu received a degree of bachelor of Medicine from Shanghai Medical University (renamed as Shanghai Medical College of Fudan University in 2000) and obtained a Ph.D degree in Neuroscience from University of Arkansas for Medical Science. After a postdoctoral fellowship in Department of Neurology in Washington University School of Medicine in St Louis he has joined and currently is a professor in School of Optometry and Ophthalmology, Wenzhou Medical University in China. His major scientific interest is focused on neurodegeneration in the central nervous system and in the retina including Alzheimer's disease.
Debomoy K. Lahiri (16607 citations) Department of Psychiatry Indiana University School of Medicine Indianapolis, IN (United States) Biography
Biography of Debomoy K. Lahiri
Dr. Debomoy Lahiri is Professor at Indiana University School of Medicine, USA. His major research focus is to understand the mechanism of aging, origin and biogenesis of the amyloid plaque, and to discover drug targets for Alzheimer's disease (AD) and other brain disorders. Dr. Lahiri’s group has shown the novel role of specific microRNA species in regulation of genes implicated in AD as well as the role of gene and environment interaction in late-life disorders. Also, his team has made significant contributions to understanding the biochemical pathway for neurodevelopment disorders, such as autism and fragile X syndrome. Dr. Lahiri is the Editor-In-Chief of the international journal, ‘Current Alzheimer Research' (Bentham). He authored books, such as ‘Protective Strategies for Neurodegenerative Diseases' published by the New York Academy of Sciences. Dr. Lahiri was awarded grants as a Principal Investigator from the National Institute on Aging, NIH, and Alzheimer’s Association, USA. His other honors include the ‘Zenith Award’ and listing in Marquis' ‘Who's Who in the World'.